GluR2-3Y peptide therapeutic (University of British Columbia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGluR2-3Y peptide therapeutic (University of British Columbia)
Drug Alias Namepeptide therapeutic (University of British Volumbia)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMetabotropic glutamate receptor 2 agonists
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A